119th CONGRESS
2d Session
H. R. 9666


To direct the Secretary of Veterans Affairs to establish a pilot program to use four-dimensional functional lung imaging software product to identify respiratory disorders and lung disease in veterans, and for other purposes.


IN THE HOUSE OF REPRESENTATIVES

July 14, 2026

Mr. Ciscomani (for himself and Mr. Pappas) introduced the following bill; which was referred to the Committee on Veterans' Affairs


A BILL

To direct the Secretary of Veterans Affairs to establish a pilot program to use four-dimensional functional lung imaging software product to identify respiratory disorders and lung disease in veterans, and for other purposes.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Advanced Imaging for Respiratory Care, Assessment, and Research Excellence for Veterans Act of 2026” or the “AIR CARE for Vets Act of 2026”.

SEC. 2. Respiratory disorder and lung disease pilot program.

(a) Establishment.—The Secretary of Veterans Affairs shall establish a pilot program to use an eligible software product to identify respiratory disorders and lung disease in veterans receiving medical services at facilities of the Department of Veterans Affairs.

(b) Leases of lung imaging software products.—The Secretary shall carry out subsection (a) by seeking to enter into an agreement with an eligible entity to lease an eligible software product to the Secretary.

(c) Expiration of authority.—The authority of the Secretary to enter into an agreement under subsection (b) shall expire on the date that is five years after the date of the enactment of this Act.

(d) Report.—Not later than 2 years after the expiration of authority under subsection (c), the Secretary shall submit to Congress a report evaluating the effectiveness of the pilot program.

(e) Authorization of appropriations.—There are authorized to be appropriated to carry out this section $5,000,000 for each of fiscal years 2027 through 2031.

(f) Definitions.—In this section:

(1) The term “eligible entity” means a developer of an eligible software product.

(2) The term “eligible software product” means a four-dimensional functional lung imaging software product that has been approved by the Food and Drug Administration to evaluate lung function.

(3) The terms “facilities of the Department” and “medical services” have the meanings given such terms in section 1701 of title 38, United States Code.